Cargando…
Famotidine and Coronavirus Disease 2019
Autores principales: | Freedberg, Daniel E., Wang, Timothy C., Abrams, Julian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833856/ https://www.ncbi.nlm.nih.gov/pubmed/33387529 http://dx.doi.org/10.1053/j.gastro.2020.12.044 |
Ejemplares similares
-
Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021) -
Reply
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
por: Freedberg, Daniel E., et al.
Publicado: (2020) -
What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
por: Singh, Vijay P., et al.
Publicado: (2021) -
Association Between Famotidine Use and COVID-19 Severity in Hong Kong: A Territory-wide Study
por: Cheung, Ka Shing, et al.
Publicado: (2021)